Clinical Trials Logo

Filter by:
NCT ID: NCT06157177 Recruiting - Clinical trials for Lumbar Spinal Stenosis

Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.

Start date: November 15, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about: - Amount and quality of pain - Interference with physical activity - Interference with sleep

NCT ID: NCT06157164 Recruiting - Clinical trials for Benign Prostatic Hyperplasia

IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation

Start date: February 6, 2023
Phase:
Study type: Observational

To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.

NCT ID: NCT06157151 Recruiting - Cervical Cancer Clinical Trials

PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Start date: June 2024
Phase: Phase 2
Study type: Interventional

This randomized trial will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab compared to pembrolizumab alone in patients with pembrolizumab-resistant recurrent or metastatic cervical cancer.

NCT ID: NCT06157099 Recruiting - Clinical trials for Clinical Stage IIA Cutaneous Melanoma AJCC v8

Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA Melanoma

Start date: April 22, 2024
Phase: Phase 2
Study type: Interventional

This clinical trial tests whether atorvastatin prevents metastasis of resected high-risk stage IIA melanoma.The vast majority of melanomas are diagnosed at an early, localized stage. However, approximately 10-15% of these localized melanomas will eventually metastasize, despite appropriate local treatment. Once metastasis occurs, median survival is less than two years. Melanomas at high risk of metastasis can be identified by gene expression profiling. Statin drugs, like atorvastatin, have been used to treat high cholesterol for the prevention of major adverse cardiovascular events, but not for preventing melanoma metastasis. Statins could prevent melanoma metastasis through decreasing tumor cell migration, decreasing tumor cell adhesion, and increasing immune system response. Statins are also efficient inhibitors of new lymphatic vessels formation. Since tumor lymphatic vessels serve as highways to lymph nodes and may suppress immune system responses, statins may block a critical step towards melanoma metastasis. Using atorvastatin may have the potential to prevent metastasis and improve outcomes in patients with resected high-risk melanoma.

NCT ID: NCT06156969 Completed - Cerebral Palsy Clinical Trials

Muscle Synergies During Gait in Children With Cerebral Palsy Undergoing Robot-assisted Gait Therapy

Start date: October 20, 2015
Phase: N/A
Study type: Interventional

This is a single-arm longitudinal study for children with cerebral palsy with gait impairments that involves robot-assisted gait training (RGT) and includes pre and post-data collection visits. The study aims to evaluate changes in muscle synergies in children with Cerebral Palsy (CP) in response to RGT. Additionally, the study aims to investigate the relationship between muscle synergies and the clinical outcomes of RGT.

NCT ID: NCT06156826 Recruiting - Pregnancy Related Clinical Trials

Prenatal Nutrient Status Study

Start date: November 7, 2023
Phase:
Study type: Observational

The purpose of this research is to gather data on nutritional status from approximately 250 pregnant women who are currently taking a prenatal vitamin in order to better understand if the prenatal vitamins that most people use are providing enough nourishment during pregnancy. Participants will be asked to: - complete an online survey - schedule a blood draw for the Study Multivitamin Blood Test - complete the blood draw visit - complete a final survey at study end

NCT ID: NCT06156605 Completed - Pain Clinical Trials

Looking Beyond the Immediate Effects of Lumbar Spinal Manipulation Using Pain Pressure Threshold in Asymptomatic Individuals

LumbarPPTUMary
Start date: September 18, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test in the effects of pain pressure threshold (PPT) looking out to 30 minutes in the lumbar spine. The main question[s] it aims to answer are: • Is there a difference between PPT from baseline, immediately after, or 30 minutes after compared to sham ultrasound control group? Participants will be exposed to sham ultrasound or sidelying lumbar manipulation with between groups and within group comparisons of PPT at the posterior superior iliac spine up to 30 minutes following the intervention.

NCT ID: NCT06156410 Recruiting - Osteosarcoma Clinical Trials

Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma

Start date: October 24, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to better understand how safe and effective the drug cabozantinib in combination with high-dose ifosfamide is in the treatment of children and adults with relapsed/refractory Ewing sarcoma and osteosarcoma.

NCT ID: NCT06156254 Recruiting - Clinical trials for COVID-19 Vaccination

Community Care Intervention to Decrease COVID-19 Vaccination Inequities

Start date: September 21, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.

NCT ID: NCT06156241 Not yet recruiting - Clinical trials for Post-Acute COVID-19 Syndrome

Stem Cell Study for Long COVID-19 Neurological Symptoms

COVID-19
Start date: January 2024
Phase: Phase 1
Study type: Interventional

The purpose of this research study is to test the safety and benefit of a human cord blood derived stem cell infusion as a treatment for individuals with post COVID-19 neurological problems. Participants in the study will have 6 clinic visits over a 12 to 14 mo. period with each visit lasting 2 to 6 hours. Participants will receive 1 stem cell infusion at study visit #3. Participants will have a brain PET and MRI scan at the baseline and 6mo. post-infusion visits. Follow-up safety assessments will be conducted at 6mo. and 1yr. after the stem cell infusion.